NICE's decision not to recommend bowel cancer drugs on the NHS has left campaigners in fighting mood.The institute says Roche's …
Thanks to spiralling costs, increasing regulation and the ever-present threat of litigious action, it is hardly surprising that pharma companies …
Pfizer's UK salesforce is likely to be in the front line following the company's decision to slash more than 250 …
London-based agency Packer Forbes Communications has won its first breast cancer account, to promote GlaxoSmithKline's potential blockbuster, Tycerb.The agency beat …
A row is brewing between doctors and the Department of Health over a major survey aimed at gauging patients' experiences …
European regulators have approved Novartis’ Lucentis, a new treatment for neovascular age-related macular degeneration, known as wet AMD.The company says …
Januvia, the first in a new class of diabetes treatments, is set for approval in the European Union.Marketed by Merck …
Newly merged biopharmaceutical company Merck Serono has awarded Huntsworth Health the UK account for one of biggest selling drugs.The agency …
Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …
A new one-stop shop website is to be created to help NHS patients choose the best services for them.Plans to …
Companies that get their working policies right not only tend to be more successful, they also make my job as …
A High Court judge is poised to decide whether the first ever legal challenge to NICE guidance can go ahead …
Viagra, the original erectile dysfunction wonder-drug could soon be available from pharmacies across Europe if its manufacturers apply for an …
Pulmonary product development in the UK has received a boost following the takeover of drug developer Innovata by biotech company …
Novartis will launch Prexige in its first European markets outside the UK next year following its EMEA approval for osteoarthritic …
The government is to work with doctors, nurses, cancer charities and others to draw up a new Cancer Reform Strategy …
The first awards have been made in the Wellcome Trust's £91 million, five-year plan for novel drugs to tackle obesity, …
Two major pharma companies could be set to follow Pfizer in using a single supply chain distributor of their medicines …
The government says GPs could help save the health service £85 million a year by switching patients on branded statins …
The head of NICE's drug appraisal process has said the institute's new fast-track system is not a "soft option" through …